drugset / Trial / NCT03126760
Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS)
RandomizedParallel-groupDouble-blindTreatment
Summary
This study will enroll about 66 participants who experienced a relapse of RRMS that steroids did not help. The doctor will put participants into a treatment group. Each person has an equal chance of being in either one of two groups (like flipping a coin). One group will receive a shot of study medicine (called Acthar Gel) under their skin every day for 14 days. The other group will receive a shot every day for 14 days, too, but there is no medicine in it (called placebo).
Timeline
- Start
- 2017-05-22
- Primary completion
- 2020-07-14
- Completion
- 2020-07-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Acthar | Peptide | 1 ml | Subcutaneous |
| Subject | Acthar | Peptide | 80 iu | Subcutaneous |